
Corporate
Agenus Outlines 2026 Priorities as Zydus Deal Closes and France Expands BOT/BAL Access to Three Tumor Types
6h ago
You're signed outSign in or to get full access.
Browse quarterly earnings call transcripts for AGENUS.
Aug 11, 2025
May 12, 2025
Mar 11, 2025
Nov 12, 2024
Aug 8, 2024
Mar 1, 2022
Nov 9, 2021
Aug 9, 2021
May 6, 2021
Mar 15, 2021
Oct 29, 2020
Aug 6, 2020
May 7, 2020
Mar 16, 2020
Nov 4, 2019